Belimumab in lupus nephritis
- PMID: 33024302
- DOI: 10.1038/s41581-020-00362-7
Belimumab in lupus nephritis
Comment on
-
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180. N Engl J Med. 2020. PMID: 32937045 Clinical Trial.
References
Original article
-
- Furie, R. et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N. Engl. J. Med 383, 1117–1128 (2020) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources